A5021409927- Lung Cancer Treatments and Mutations
- Colorectal Cancer Treatments and Studies
- Gastric Cancer Management and Outcomes
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Research Studies
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
- HER2/EGFR in Cancer Research
- PI3K/AKT/mTOR signaling in cancer
- Inflammatory Biomarkers in Disease Prognosis
- Immunotherapy and Immune Responses
- Lipid metabolism and disorders
- Neutropenia and Cancer Infections
- Neuroendocrine Tumor Research Advances
- Hepatitis B Virus Studies
- Cancer Mechanisms and Therapy
- Liver Disease Diagnosis and Treatment
- Biosimilars and Bioanalytical Methods
- Cytokine Signaling Pathways and Interactions
- Chronic Lymphocytic Leukemia Research
- Medical Imaging and Pathology Studies
- Genetic factors in colorectal cancer
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Prince of Wales Hospital
2022-2025
Chinese University of Hong Kong
2015-2024
A number of circulating inflammatory factors are implicated in the pathogenesis and prognostication hepatocellular carcinoma (HCC). We aim to evaluate multiple serum simultaneously develop an objective score for HCC.A prospective cohort 555 patients with HCC paired samples was accrued from 2009 2012. The blood levels conventional markers, namely C-reactive protein (CRP), albumin, neutrophils, lymphocytes platelet, were determined, 41 other exploratory markers measured by a multiplex assay....
IntroductionInterstitial drug disease (ILD) is the most frequent cause of drug-related mortality from epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI).Yet, for patients with symptomatic osimertinib-induced ILD, risk recurrent ILD associated EGFR TKI rechallenge, either osimertinib or another TKI, such as erlotinib, unclear. MethodsRetrospective study 913 who received treatment EGFRmutation positive non-small cell lung cancer (NSCLC).Clinical characteristics, history,...